How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis

BMC Musculoskeletal Disorders

Volumn 15, Issue 1, 2014, Pages

  Siemons, Liseth ^a   Ten Klooster, Peter M ^a   Vonkeman, Harald E ^a,b   Van Riel, Piet L C M ^c   Glas, Cees A W ^a   Van De Laar, Mart A F J ^a,b  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Age; Body mass index (BMI); C reactive protein (CRP); Early rheumatoid arthritis (RA); Erythrocyte sedimentation rate (ESR); Sex

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; PREDNISOLONE;

ADULT; AGING; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE REGISTRY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEALTH STATUS; HUMAN; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; PROTEIN DETERMINATION; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; WEIGHT GAIN; AGED; ARTHRITIS, RHEUMATOID; BLOOD; CLINICAL TRIAL; ERYTHROCYTE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; SEXUAL DEVELOPMENT;

ADULT; AGED; AGING; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; COHORT STUDIES; ERYTHROCYTES; FEMALE; HUMANS; MALE; MIDDLE AGED; SEX CHARACTERISTICS;

EID: 84920864140     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-15-368     Document Type: Article

References (36)

1. Felson DT, Smolen JS, Wells G, Zhang B, Van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, Brooks P, Brown A, Matucci-Cerinic M, Choi H, Combe B, De Wit M, Dougados M, Emery P, Furst D, Gomez-Reino J, Hawker G, Keystone E, Khanna D, Kirwan J, Kvien TK, Landewé R, Listing J, Michaud K, Martin-Mola E, Montie P, et al: American College of Rheumatology/ European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 2011, 63:573-586.
2. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt M, Wildmark R, Williams J, Wolfe F: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The committee on outcome measures in rheumatoid arthritis clinical trials. Arthritis Rheum 1993, 36:729-740.
3. Prevoo ML, Van't Hof MA, Kuper HH, Van Leeuwen MA, Van De Putte LB, Van Riel PL: Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48.
4. Firestein GS, Budd RC, Harris ED Jr, McInnes IB, Ruddy S, Sergent JS: Kelly's Textbook of Rheumatology. Philadelphia: Saunders Elsevier; 2009.
5. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, De Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, Van der Heijde D: Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010, 69:631-637.
6. Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, Emery P, Ferraccioli G, Hazes JM, Klareskog L, Machold K, Martin-Mola E, Nielsen H, Silman A, Smolen J, Yazici H: EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007, 66:34-45.
7. Turkiewicz AM, Moreland LW: Rheumatoid arthritis. In Clinical Care in the Rheumatic Diseases. Edited by Bartlett SJ. Atlanta (GA): Association of Rheumatology Health Professionals; 2006:157-166.
8. Lee DM, Weinblatt ME: Rheumatoid arthritis. Lancet 2001, 358:903-911.
9. Kushner I: C-reactive protein in rheumatology. Arthritis Rheum 1991, 34:1065-1068.
10. Nestel AR: ESR changes with age - a forgotten pearl. BMJ 2012, 344:e1403.
11. Miller A, Green M, Robinson D: Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed) 1983, 286:266.
12. Shearn MA, Kang IY: Effect of age and sex on the erythrocyte sedimentation rate. J Rheumatol 1986, 13:297-298.
13. De Silva DA, Woon FP, Chen C, Chang HM, Wong MC: Serum erythrocyte sedimentation rate is higher among ethnic South Asian compared to ethnic Chinese ischemic stroke patients. Is this attributable to metabolic syndrome or central obesity? J Neurol Sci 2009, 276:126-129.
14. Böttiger LE, Svedberg CA: Normal erythrocyte sedimentation rate and age. Br Med J 1967, 2:85-87.
15. Radovits BJ, Fransen J, Van Riel PL, Laan RF: Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis. Ann Rheum Dis 2008, 67:1127-1131.
16. Ranganath VK, Elashoff DA, Khanna D, Park G, Peter JB, Paulus HE: Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients. J Rheumatol 2005, 32:1040-1042.
17. Hayes GS, Stinson IN: Erythrocyte sedimentation rate and age. Arch Ophthalmol 1976, 94:939-940.
18. Oeser A, Chung CP, Asanuma Y, Avalos I, Stein CM: Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus. Arthritis Rheum 2005, 52:3651-3659.
19. Fransen J, Welsing PMJ, de Keijzer RMH, Van Riel PLCM: Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis 2003, 62:151.
20. Crowson CS, Rahman MU, Matteson EL: Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis. J Rheumatol 2009, 36:1606-1610.
21. Kawamoto R, Kusunoki T, Abe M, Kohara K, Miki T: An association between body mass index and high-sensitivity C-reactive protein concentrations is influenced by age in community-dwelling persons. Ann Clin Biochem 2013, 50:457-464.
22. Piéroni L, Bastard JP, Piton A, Khalil L, Hainque B, Jardel C: Interpretation of circulating C-reactive protein levels in adults: body mass index and gender are a must. Diabetes Metab 2003, 29:133-138.
23. Lee YJ, Lee JH, Shin YH, Kim JK, Lee HR, Lee DC: Gender difference and determinants of C-reactive protein level in Korean adults. Clin Chem Lab Med 2009, 47:863-869.
24. Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D'Agostino RB Jr, Herrington DM: Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J 2006, 152:593-598.
25. Rommel J, Simpson R, Mounsey JP, Chung E, Schwartz J, Pursell I, Gehi A: Effect of body mass index, physical activity, depression, and educational attainment on high-sensitivity C-reactive protein in patients with atrial fibrillation. Am J Cardiol 2013, 111:208-212.
26. Kao TW, Lu IS, Liao KC, Lai HY, Loh CH, Kuo HK: Associations between body mass index and serum levels of C-reactive protein. S Afr Med J 2009, 99:326-330.
27. Rawson ES, Freedson PS, Osganian SK, Matthews CE, Reed G, Ockene IS: Body mass index, but not physical activity, is associated with C-reactive protein. Med Sci Sports Exerc 2003, 35:1160-1166.
28. Vermeer M, Kuper HH, Hoekstra M, Haagsma CJ, Posthumus MD, Brus HL, Van Riel PL, Van de Laar MA: Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch rheumatoid arthritis monitoring remission induction cohort study. Arthritis Rheum 2011, 63:2865-2872.
29. Siemons L, ten Klooster PM, Vonkeman HE, Glas CAW, Van de Laar MAFJ: Distinct trajectories of disease activity over the first year in early rheumatoid arthritis patients following a treat-to-target strategy. Arthritis Care Res 2014, 66:625-630.
30. Fries JF, Spitz P, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum 1980, 23:137-145.
31. Ware JE, Kosinski M, Dewey JE: How to Score Version Two of the SF-36 Health Survey. Lincoln, RI: QualityMetric, Incorporated; 2000.
32. Albert MA, Glynn RJ, Ridker PM: Effect of physical activity on serum Creactive protein. Am J Cardiol 2004, 93:221-225.
33. Husain TM, Kim DH: C-reactive protein and erythrocyte sedimentation rate in orthopaedics. Univ Pa Orthop J 2002, 15:13-16.
34. Vermeer M, Kievit W, Kuper HH, Braakman-Jansen LM, Bernelot Moens HJ, Zijlstra TR, den Broeder AA, Van Riel PL, Fransen J, Van De Laar MA: Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry. BMC Musculoskelet Disord 2013, 14:350.
35. Young A, Dixey J, Cox N, Davies P, Devlin J, Emery P, Gallivan S, Gough A, James D, Prouse P, Williams P, Winfield J: How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Rheumatology (Oxford) 2000, 39:603-611.
36. Albers JM, Paimela L, Kurki P, Eberhardt KB, Emery P, van't Hof MA, Schreuder FH, Leirisalo-Repo M, Van Riel PL: Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis. Ann Rheum Dis 2001, 60:453-458.